New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study

被引:15
|
作者
Sadat-Ebrahimi, Seyed Esmaeil [1 ]
Rahmani, Abbas [1 ]
Mohammadi-Khanaposhtani, Maryam [2 ]
Jafari, Negar [3 ]
Mojtabavi, Somayeh [4 ]
Faramarzi, Mohammad Ali [4 ]
Emadi, Mehdi [5 ]
Yahya-Meymandi, Azadeh [6 ]
Larijani, Bagher [7 ]
Biglar, Mahmoud [7 ]
Mahdavi, Mohammad [7 ]
机构
[1] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm & Pharmaceut Sci, Res Ctr, Tehran, Iran
[2] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Hlth Res Inst, Babol Sar, Iran
[3] Univ Kansas, Fac Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
[4] Univ Tehran Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm & Biotechnol, Res Ctr, Tehran, Iran
[5] Babol Noshirvani Univ Technol, Elect & Comp Engn Dept, Babol Sar, Iran
[6] Univ Birjand, Dept Chem, Fac Sci, Birjand, Iran
[7] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
关键词
Phthalimide; Benzamide; 1,2,3-Triazole; Hybrid; alpha-Glucosidase; PHTHALIMIDE DERIVATIVES; MOLECULAR DOCKING; MECHANISM;
D O I
10.1007/s00044-020-02522-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new series of phthalimide-benzamide-1,2,3-triazole hybrids 8a-k as alpha-glucosidase inhibitors was designed and synthesized. The biological evaluation of compounds 8a-k against yeast alpha-glucosidase demonstrated that all they have excellent inhibitory activity in comparison with standard inhibitor acarbose. Among them, the most potent compound was compound 8d with inhibitory activity 18.5-fold more than acarbose. Kinetic study revealed that alpha-glucosidase inhibition of compound 8d was the competitive type. Furthermore, docking study suggested that compound 8d is more stable than acarbose in the active site of alpha-glucosidase.
引用
收藏
页码:868 / 876
页数:9
相关论文
共 50 条
  • [31] New 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: synthesis, in vitro and in silico enzymatic and toxicity evaluations
    Sepehri, Nima
    Azizian, Homa
    Ghadimi, Reza
    Abedinifar, Fahimeh
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Moghadamnia, Ali Akbar
    Zabihi, Ebrahim
    Mohebbi, Gholamhossein
    Larijani, Bagher
    Hamedifar, Haleh
    Mohammadi-Khanaposhtani, Maryam
    Mahdavi, Mohammad
    MONATSHEFTE FUR CHEMIE, 2021, 152 (06): : 679 - 693
  • [32] Quinoline-linked 1,2,3-Triazole Hybrids: Design, Synthesis, Anticancer Activity and Computational Investigations
    Bhukya, Rambabu
    Vanga, Murali Krishna
    Bhukya, Chandulal
    Thumma, Vishnu
    Jadhav, Ramchander
    CHEMISTRY & BIODIVERSITY, 2025,
  • [33] 2,4-Dioxochroman Moiety Linked to 1,2,3-triazole Derivatives as Novel α-glucosidase Inhibitors: Synthesis, In vitro Biological Evaluation, and Docking Study
    Mollazadeh, Marjan
    Mohammadi-Khanaposhtani, Maryam
    Valizadeh, Yousef
    Zonouzi, Afsaneh
    Faramarzi, Mohammad Ali
    Hariri, Parsa
    Biglar, Mahmood
    Larijani, Bagher
    Hamedifar, Haleh
    Mahdavi, Mohammad
    Sepehri, Nima
    CURRENT ORGANIC CHEMISTRY, 2020, 24 (17) : 2019 - 2027
  • [34] Hyaluronidase Inhibitory Activity and In Silico Docking Study of New Eugenol 1,2,3-triazole Derivatives
    Elattar, Eman M.
    Galala, Amal A.
    Saad, Hassan-Elrady A.
    Badria, Farid A.
    CHEMISTRYSELECT, 2022, 7 (42):
  • [35] New 1,2,3-triazole-(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation
    Asgari, Mohammad S.
    Azizian, Homa
    Nazari Montazer, Mohammad
    Mohammadi-Khanaposhtani, Maryam
    Asadi, Mehdi
    Sepehri, Saghi
    Ranjbar, Parviz R.
    Rahimi, Rahmatollah
    Biglar, Mahmood
    Larijani, Bagher
    Amanlou, Massoud
    Mahdavi, Mohammad
    ARCHIV DER PHARMAZIE, 2020, 353 (09)
  • [36] The Search for New Antibacterial Agents among 1,2,3-Triazole Functionalized Ciprofloxacin and Norfloxacin Hybrids: Synthesis, Docking Studies, and Biological Activity Evaluation
    Hryhoriv, Halyna
    Mariutsa, Illia
    Kovalenko, Sergiy M.
    Georgiyants, Victoriya
    Perekhoda, Lina
    Filimonova, Nataliia
    Geyderikh, Olga
    Sidorenko, Lyudmila
    SCIENTIA PHARMACEUTICA, 2022, 90 (01)
  • [37] Synthesis and biological assessment of benzimidazole-acrylonitrile-1,2,3-triazole derivatives as α-glucosidase inhibitors
    Hatamfayazi, Mahdi
    Mahdavi, Mohammad
    Dehaghi, Shahram Moradi
    Khoshneviszadeh, Mehdi
    Iraji, Aida
    BIOORGANIC CHEMISTRY, 2025, 154
  • [38] Discovery of Phthalimide-1,2,3-triazole-N-phenylacetamide Hybrids as Potent a-Glucosidase Inhibitors: Design, Synthesis, ADMET Prediction, and in vitro and in silico Enzymatic Evaluations
    Gavanrudi, Mahtab Rahmani
    Halimi, Mohammad
    Najafzadehvarzi, Hossein
    Alikhani, Majid
    Moazzam, Ali
    Farzipour, Soghra
    Hosseini, Samanesadat
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Nasli-Esfahani, Ensieh
    Mohammadi-Khanaposhtani, Maryam
    Mahdavi, Mohammad
    CHEMISTRYSELECT, 2023, 8 (26):
  • [39] Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies
    Reddyrajula, Rajkumar
    Dalimba, Udayakumar
    Kumar, S. Madan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 : 263 - 282
  • [40] New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study
    El Azab, Islam H.
    El-Sheshtawy, Hamdy S.
    Bakr, Rania B.
    Elkanzi, Nadia A. A.
    MOLECULES, 2021, 26 (03):